Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood

Hippocampus

Volumn 19, Issue 8, 2009, Pages 763-772

  Rubino, Tiziana ^a   Realini, Natalia ^a   Braida, Daniela ^b   Guidi, Sandra ^c   Capurro, Valeria ^b   Viganò, Daniela ^a,d   Guidali, Cinzia ^a   Pinter, Marta ^a   Sala, Mariaelvina ^b   Bartesaghi, Renata ^c   Parolaro, Daniela ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Zardi Gori Foundation   (Italy)

Author keywords

Adolescence; Cannabinoids; Golgi Cox staining; Spatial memory; Synaptic markers

Indexed keywords

DRONABINOL; GLIAL FIBRILLARY ACIDIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOBREVIN 2;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CELL SIZE; CELL STRUCTURE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; DRUG EXPOSURE; EXPERIMENTAL MODEL; GOLGI STAIN; HIPPOCAMPUS; LEARNING DISORDER; LONG TERM EXPOSURE; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PASSIVE AVOIDANCE; PERINATAL PERIOD; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; SPINE; TISSUE STRUCTURE; WORKING MEMORY;

AGING; ANIMALS; AVOIDANCE LEARNING; COGNITION DISORDERS; DENDRITES; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAZE LEARNING; MEMBRANE PROTEINS; MEMORY; NEURONAL PLASTICITY; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTOPHYSIN; TETRAHYDROCANNABINOL; TUBULIN; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2;

EID: 67449147859     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20554     Document Type: Article

References (70)

1. Amaral DG, Witter MP. 1995. Hippocampal formation. In: Paxinos G, editor. The Rat Nervous System. San Diego, CA: Academic Press. pp 443-492.
2. Bailey CH, Kandel ER. 1993. Structural changes accompanying memory storage. Annu Rev Physiol 55:397-426.
3. Bartesaghi R, Ravasi L. 1999. Pyramidal neuron types in field CA2 of the guinea pig. Brain Res Bull 50:263-273.
4. Bird CM, Burgess N. 2008. The hippocampus and memory: Insights from spatial processing. Nat Rev Neurosci 9:82-94.
5. Boehler MD, Wheeler BC, Brewer GJ. 2007. Added astroglia promote greater synapse density and higher activity in neuronal networks. Neuron Glia Biol 3:127-140.
6. Braida D, Sacerdote P, Panerai AE, Bianchi M, Aloisi A, Iosuè S, Sala M. 2004. Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav Brain Res 153:423-429.
7. Carmignoto G. 2000. Reciprocal communication system between astrocytes and neurones. Prog Neurobiol 62:561-581.
8. Cha YM, Jones KH, Kuhn CM, Wilson WA, Swartzwelder HS. 2007. Sex differences in the effects of Δ9 tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav Pharmacol 18:563-569.
9. Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS. 2006. Differential effects of delta 9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav 83:448-455.
10. Davis S, Butcher SP, Morris RG. 1992. The NMDA receptor antagonist d-2-amino-5-phosphonopentanoate (d-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci 12:21-34.
11. Deák F, Shin OH, Kavalali ET, Südhof TC. 2006. Structural determinants of synaptobrevin 2 function in synaptic vesicle fusion. J Neurosci 26:6668-6676.
12. Dráberová E, Del Valle L, Gordon J, Marková V, Smejkalová B, Bertrand L, de Chadarévian JP, Agamanolis DP, Legido A, Khalili K, Dráber P, Katsetos CD. 2008. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: Implications for phenotypic identity. J Neuropathol Exp Neurol 67:341-354.
13. Durston S, Hulshoff Pol HE, Casey BJ, Giedd JN, Buitelaar JK, van Engeland H. 2001. Anatomical MRI of the developing human brain: What have we learned? J Am Acad Child Adolesc Psychiatry 40:1012-1020.
14. Glantz LA, Gilmore JH, Hamer RM, Lieberman JA, Jarskog LF. 2007. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. Neuroscience 149:582-591.
15. Guidi S, Severi S, Ciani E, Bartesaghi R. 2006. Sex differences in the hilar mossy cells of the Guinea-pig before puberty. Neuroscience 139:565-576.
16. Harris KM, Kater SB. 1994. Dendritic spines: Cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 17:341-371.
17. Hata Y, Takai Y. 1999. Roles of postsynaptic density-95/synapse- associated protein 90 and its interacting proteins in the organization of synapses. Cell Mol Life Sci 56:461-472.
18. Heffner TG, Hartman JA, Seiden LS. 1980. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13:453-456.
19. Hertz L, Zielke HR. 2004. Astrocytic control of glutamatergic activity: Astrocytes as stars of the show. Trends Neurosci 27:735-743.
20. Hunt CA, Schenker LJ, Kennedy MB. 1996. PSD-95 is associated with the postsynaptic density and not with the presynaptic membrane at forebrain synapses. J Neurosci 16:1380-1388.
21. Huttenlocher PR. 1990. Morphometric study of human cerebral cortex development. Neuropsychologia 28:517-527.
22. Huttenlocher PR, Dabholkar AS. 1997. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387:167-178.
23. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR. 2004. Impact of cannabis use on brain function in adolescents. Ann N Y Acad Sci 1021:384-390.
24. Janz R, Südhof TC, Hammer RE, Unni V, Siegelbaum SA, Bolshakov VY. 1999. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 24:687-700.
25. Kesner RP. 2007. A behavioral analysis of dentate gyrus function. Prog Brain Res 163:567-576.
26. Kim D, Thayer SA. 2001. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J Neurosci 21: RC146.
27. Kim E, Sheng M. 2004. PDZ domain proteins of synapses. Nat Rev Neurosci 5:771-781.
28. Kolb B, Forgie M, Gibb R, Gorny G, Rowntree S. 1998. Age, experience and the changing brain. Neurosci Biobehav Rev 22:143-159.
29. Kolb B, Gorny G, Limebeer CL, Parker LA. 2006. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats. Synapse 60:429-436.
30. McGregor A, Hayward AJ, Pearce JM, Good MA. 2004. Hippocampal lesions disrupt navigation based on the shape of the environment. Behav Neurosci 118:1011-1021.
31. Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, Makhinson M, He Y, Ramsay MF, Morris RG, Morrison JH, O'Dell TJ, Grant SG. 1998. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396:433-439.
32. Mong JA, Blutstein T. 2006. Estradiol modulation of astrocytic form and function: Implications for hormonal control of synaptic communication. Neuroscience 138:967-975.
33. Morris RGM, Garrud P, Rawlins JN, O'Keefe J. 1982. Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683.
34. Moser MB. 1999. Making more synapses: A way to store information? Cell Mol Life Sci 55:593-600.
35. Newell KA, Zavitsanou K, Huang XF. 2007. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment. J Neural Transm 114:995-1001.
36. NIDA. 2005. NIDA Research Monograph Series: Marijuana Abuse. NIH.
37. Okabe S, Kim HD, Miwa A, Kuriu T, Okado H. 1999. Continual remodeling of postsynaptic density and its regulation by synaptic activity. Nat Neurosci 2:804-811.
38. O'shea M, McGregor IS, Mallet PE. 2006. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar long- lasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol 20:611-621.
39. O'shea M, Singh ME, McGregor IS, Mallet PE. 2004. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol 18:502-508.
40. Olton DS, Becker JT, Handelman GE. 1979. Hippocampus, space, and memory. Behav Brain Sci 2:313-365.
41. Owen J. 2007.Cannabis: An Apology. The Independent on Sunday, 18 March. pp 8-11.
42. Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A. 2001. Maturation of white matter in the human brain: A review of magnetic resonance studies. Brain Res Bull 54:255-266.
43. Paxinos G, Watson C. 2005. The Rat Brain in Stereotaxic Coordinates. Burlington, MA: Elsevier Academic Press.
44. Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. 2001. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58:909-915.
45. Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA, Matsuda-Matsumoto H, Iwazaki T, McGregor IS. 2008. Adolescent rats find repeated delta(9)-thc less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacol 33:1113-1126.
46. Ramon-Moliner E. 1958. A tungstate modification of the Golgi-Cox method. Stain Technol 33:19-29.
47. Ranganathan M, D'souza DC. 2006. The acute effects of cannabinoids on memory in humans: A review. Psychopharmacol 188:425-444.
48. Rawlins JN, Olton DS. 1982. The septo-hippocampal system and cognitive mapping. Behav Brain Res 5:331-358.
49. Ricalde AA, Hammer RP Jr. 1990. Perinatal opiate treatment delays growth of cortical dendrites. Neurosci Lett 115:137-143.
50. Rice D, Barone S Jr. 2000. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ Health Perspect 108 (Suppl 3):511-533.
51. Riedel G, Davies SN. 2005. Cannabinoid function in learning, memory and plasticity. Handb Exp Pharmacol 168:445-477.
52. Robinson TE, Gorny G, Savage VR, Kolb B. 2002. Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neo cortex of adult rats. Synapse 46:271-279.
53. Rubino T, Vigano' D, Realini N, Guidali C, Braida D, Capurro V, Castiglioni C, Cherubino F, Romualdi P, Candeletti S, Sala M, Parolaro D. 2008. Chronic delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: Behavioral and biochemical correlates. Neuropsychopharmacology 33:2760-2771.
54. Sala M, Braida D, Calcaterra P, Leone MP, Comotti FA, Gianola S, Gori E. 1991. Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat. Eur J Pharmacol 194:45-49.
55. SAMHSA. 2004. Substance Abuse and Mental Health Service Administration. Results from the 2003 National Survey on Drug Use and Helath: National Findings, Office of Applied Studies, NSDUH Series H-25. DHHS: Rockville, MD.
56. Schneider M, Koch M. 2003. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28:1760-1769.
57. Schneider M, Koch M. 2007. The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion. Eur Neuropsychopharmacol 17:180-186.
58. Schoch S, Deák F, Königstorfer A, Mozhayeva M, Sara Y, Südhof TC, Kavalali ET. 2001. SNARE function analyzed in synaptobrevin/ VAMP knockout mice. Science 294:1117-1122.
59. Schweinsburg AD, Brown SA, Tapert SF. 2008. The influence of marijuana use on neurocognitive functioning in adolescents. Current Drug Abuse Reviews 1:99-111.
60. Sheng M, Pak DT. 1999. Glutamate receptor anchoring proteins and the molecular organization of excitatory synapses. Ann N Y Acad Sci 868:483-493.
61. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE. 1993. SNAP receptors implicated in vesicle targeting and fusion. Nature 362:318-324.
62. Solowij M, Battisti R. 2008. The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews 1:81-98.
63. Südhof TC, Jahn R. 1991. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron 6:665-677.
64. Svendsen CN, Bhattacharyya A, Tai Y-T. 2001. Neurons from stem cells: Preventing an identity crisis. Nat Rev Neurosci 2:831-834.
65. Viveros MP, Llorente R, Moreno E, Marco EM. 2005. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol 16:353-362.
66. Weinstein DE, Shelanski ML, Liem RK. 1991. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112:1205-1213.
67. Wojcik SM, Brose N. 2007. Regulation of membrane fusion in synaptic excitation-secretion coupling: Speed and accuracy matter. Neuron 55:11-24.
68. Woolley CS, Gould E, Frankfurt M, McEwen BS. 1990. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 10:4035-4039.
69. Woolley CS, McEwen BS. 1992. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12:2549-2554.
70. Xu K, Malouf AT, Messing A, Silver J. 1999. Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. Glia 25:390-403.